Viral inhibition of interferon signal transduction

Intervirology

Volumn 42, Issue 5-6, 1999, Pages 325-330

  Cebulla, Colleen M ^a   Miller, Daniel M ^a   Sedmak, Daniel D ^a,b  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b 129 Hamilton Hall ^*  (United States)

Author keywords

Adenovirus; Cytomegalovirus; Ebola virus; Epstein Barr virus; Hepatitis B virus; Human papilloma virus; Interferon signal transduction; JAK STAT pathway; Mumps Varicella zoster virus

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; DOUBLE STRANDED DNA; INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN; PROTEIN KINASE;

ANTIGEN PRESENTATION; CONFERENCE PAPER; GENETIC TRANSCRIPTION; IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS INHIBITION;

ADENOVIRIDAE; CYTOMEGALOVIRUS; EBOLA VIRUS; HEPATITIS B VIRUS; HUMAN HERPESVIRUS 3; HUMAN HERPESVIRUS 4; HUMAN PAPILLOMA VIRUS; PAPILLOMAVIRUS;

EID: 0343446139     PISSN: 03005526     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053968     Document Type: Conference Paper

References (56)

1. Samuel CE: Antiviral actions of interferon interferon-regulated cellular proteins and their surprisingly selective antiviral activities. Virology 1991;183:1-11.
2. Vilcek J, Sen GC: Interferons and other cytokines; in Fields BN, Knipe DM, Howley PM (eds): Fields Virology. Philadelphia, Lippincott-Raven 1996, pp 341-365.
3. Boss JM: Regulation of transcription of MHC class II genes. Curr Opin Immunol 1997;9: 107-113.
4. Darnell JE, Kerr IM, Stark GR: Jak-Stat pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994;264:1415-1421.
5. Martin B, Chin K, Olsen J, Skinner C, Dey A, Ozato K, Ting J: Induction of MHC class I expression by the MHC class II transactivator CIITA. Immunity 1997;6:591-600.
6. Yeow W-S, Lawson CM, Beilharz MW: Antiviral activities of individual murine IFN-(alpha) subtypes in vivo: Intramuscular injection of IFN expression constructs reduces cytomegalovirus replication. J Immunol 1998;160:2932-2939.
7. Presti RM, Pollock JL, Dal Canto AJ, O'Guin AK, Virgin HW: Interferon-γ regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels. J Exp Med 1998;188:577-588.
8. Martinotti MG, Gribaudo G, Gargiglio M, Caliendo A, Lembo D, Angeretti A, Cavallo R, Landolfo S: Effect of interferon-α on immediate early gene expression of murine cytomegalovirus. J Interferon Res 1993;13:105-109.
9. Gribaudo G, Ravaglia S, Caliendo A, Cavallo R, Gariglio M, Martinotti MG, Landolfo S: Interferons inhibit onset of murine cytomegalovirus immediate-early gene transcription. Virology 1993;197:303-311.
10. Hirsch MS, Schooley RT, Cosimi AB, Russell PS, Delmonico FL, Tolkoff-Rubin NE, Herrin JT, Cantell K, Farrell M-L, Rota TR, Rubin RH: Effects of interferon-alpha on cytomegalovirus reactivation syndromes in renal-transplant recipients. N Engl J Med 1983;308:1489-1493.
11. Biron CA: Cytokines in the generation of immune responses to, and resolution of, virus infection. Curr Opin Immunol 1994;6:530-538.
12. Kawaguchi Y, Bruni R, Roizman B: Interaction of herpes simplex virus I alpha regulatory protein ICP0 with elongation factor 1 delta: ICP0 affects translational machinery. J Virol 1997;71:1019-1024.
13. Orange JS, Wang B, Terhorst C, Biron CA: Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med 1995;182:1045-1056.
14. Jonjic S, Mutter W, Weiland F, Reddehase MJ, Koszinowski UH: Site-restricted persistent cytomegalovirus infection after selective longterm depletion of CD4 T lymphocytes. J Exp Med 1989;169:1199-1212.
15. Lucin P, Pavic I, Polie B, Jonjic S, Koszinowski UH: Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands. J Virol 1992;66:1977-1984.
16. Davignon J-L, Castanie P, Yorke JA, Gautier N, Clement D, Davrinche C: Anti-human cytomegalovirus activity of cytokines produced by CD4+ T-cell clones specifically activated by IE1 peptides in vitro. J Virol 1996;70:2162-2169.
17. Heise MT, Virgin HW: The T-cell-independent role of gamma interferon and tumor necrosis factor alpha in macrophage activation during murinc cytomegalovirus and herpes simplex virus infections. J Virol 1995;69:904-909.
18. Lucin P, Jonjic S, Messerle M, Polic B, Hengel H, Koszinowski U: Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor. J Gen Virol 1994;75:101-110.
19. Schut RL, Gekker G, Hus S, Chao CC, Pomeroy C, Jordan MC, Peterson PK: Cytomegalovirus replication in murine microglial cell cultures: Suppression of permissive infection by interferon-γ. J Infect Dis 1994;169:1092-1096.
20. Hengel H, Eblinger C, Pool J, Goulmy E, Koszinowski UH: Cytokines restore MHC class I complex formation and control antigen presentation in human cytomegalovirus-infected cells. J Gen Virol 1995;76:2987-2997.
21. Hengel H, Lucin P, Jonjic S, Ruppert T, Koszinowski UH: Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape. J Virol 1994;68:289-297.
22. Haagmans BL, van der Meide PH, Stals FS, van der Eertwegh AJM, Claassen E, Bruggeman CA, Horzinck MC, Schijns VECJ: Suppression of rat cytomegalovirus replication by antibodies against gamma interferon. J Virol 1994;68:2305-2312.
23. Durbin JE, Hackermiller R, Simon MC, Levy DE: Targeted disruption of the mouse STAT1 gene results in compromised innate immunity to viral disease. Cell 1996;84:443-450.
24. Lew DJ, Decker T, Strehlow I, Darnell JE: Overlapping elements in the guanylate-binding protein gene promoter mediate transcriptional induction by alpha and gamma interferons. Mol Cell Biol 1991;11:182-191.
25. Schindler C, Shuai K, Prezioso VR, Darnell JE: Interferon-dependent tyrosinc phosphorylation of a latent cytoplasmic transcription factor. Science 1992;257:809-813.
26. Ghislain JJ, Fish EN: Application of genomic DNA affinity chromatography identifies multiple interferon-alpha-regulated Stat2 complexes. J Biol Chem 1996;271:12408-12413.
27. Li X, Leugn S, Kerr IM, Stark GR: Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling. Mol Cell Biol 1997;17:2048-2056.
28. Haque SJ, Williams BRG: Identification and characterization of an interferon (IFN)-stimulated response element-IFN-stimulated gene factor 3-independent signaling pathway for IFN-alpha. J Biol Chem 1994;269:19523-19529.
29. Li X, Leung S, Qureshi S, Darnell JE, Stark GR: Formation of Stal1-Stat2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-alpha. J Biol Chem 1996;271:5790-5794.
30. Hibino Y, Kumar CS, Mariano TM, Lai D, Pestka S: Chimeric interferon-γ receptors demonstrate that an accessory factor required for activity interacts with the extracellular domain. J Biol Chem 1992;267:3741-3749.
31. Shuai K, Stark GR, Kerr IM, Darnell JEJ: A simple phosphotyrosine residue of stat91 required for gene activation by interferon-gamma. Science 1993;261:1744-1746.
32. Schindlet C, Darnell JE: Transcriptional responses to polypeptide ligands: The Jak-Stat pathway. Annu Rev Biochem 1995;64:621-651.
33. Gutch MJ, Reich NC: Repression of the interferon signal transduction pathway by the adenovirus E1A oncogene. Proc Natl Acad Sci USA 1991;88:7913-7917.
34. Leonard GT, Sen GC: Effects of adenovirus E1A protein on interferon-signaling. Virology 1996;224:25-33.
35. Leonard GT, Sen GC: Restoration of interferon responses of adenovirus E1A-expressing HT1080 cell lines by overexpression of p48 protein. J Virol 1997;71:5095-5101.
36. Kalvakolanu DVR, Bandyopadhyay SK, Harter ML, Sen GC: Inhibition of the interferon inducible gene expression by adenovirus E1A proteins: Block in transcriptional complex formation. Proc Natl Acad Sci USA 1991;88: 7459-7463.
37. Mahr JA, Gooding LR: Immune evasion by adenoviruses. Immunol Rev 1999;168:121-130.
38. Anderson KP, Fennie EH: Adenovirus early region 1A modulation of interferon antiviral activity. J Virol 1987;61:787-795.
39. Takeda T, Nakajima K, Kojima H, Hirano T: E1A repression of IL-6-induced gene activation by blocking the assembly of IL-6 response element binding complexes. J Immunol 1994;153: 4573-4582.
40. Barnard P, McMillan NAJ: The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-α. Virology 1999;259: 305-313.
41. Fujii N, Oguma K, Kimura K, Yamashita T, Ishida S, Fujinaga K, Yashiki T: Oligo-2′,5′-adenylate synthetase activity in K562 cell lines persistently infected with measles or mumps virus. J Gen Virol 1988;69:2085-2091.
42. Fujii N, Kimura K, Murakami T, Indoh T, Ishida S, Fujinaga K, Oguma K: Suppression of interferon-induced oligo-2′,5′-adenylate synthetase induction in persistent infection. J Gen Virol 1990;71:3071-3074.
43. Fujii N, Yokosawa N, Ishida S, Shirakawa S, Kubota T, Indoh T, Fujinaga K, Yashiki T: Investigation of IFN type-I receptor and IFN regulatory factor expression relating to induction of 2′,5′-oligoadenylate synthetase in cells persistently infected with the mumps virus. Microbiol Immunol 1996;40:777-781.
44. Yokosawa N, Kubota T, Fujii N: Poor induction of interferon-induced 2′5′-oligoadenylate synthetase (2-5 AS) in cells persistently infected with mumps virus is caused by decrease of STAT-1α. Arch Virol 1998;143:1985-1992.
45. Peters CJ, Sanchez A, Rollin PE, Ksiazek TG, Murphy FA: Filoviridae: Marburg and Ebola viruses; in Fields BN, Knipe DM, Howley PM (eds): Fields Virology, New York, Lippincott-Raven, 1996, vol 1, pp 1161-1176.
46. Harcourt BH, Sanchez A, Offermann MK: Ebola virus selectively inhibits responses to interferons, but not to interleukin-1β, in endothelial cells. J Virol 1999;73:3491-3496.
47. Foster GR, Ackrill AM, Goldin RD, Kerr IM, Thomas HC, Stark GR: Expression of the terminal protein region of hepatitis B virus inhibits cellular responses to interferons α and γ and double-stranded RNA. Proc Natl Acad Sci USA 1991;88:2888-2892.
48. Kanda K, Decker T, Aman P, Wahlstrom M, von Gabain A, Kallin B: The EBNA2-related resistance towards alpha interferon in Burkitt's lymphoma cells effects induction of IFN-induced genes but not the activation of transcription factor ISGF3. Mol Cell Biol 1992;12: 4930-4936.
49. Aman P, von Gabain A: An Epstein-Barr virus immortalization associated gene segment interferes specifically with the IFN-induced antiproliferative response in human B-lymphoid cell lines. EMBO J 1990;9:147-152.
50. Miller DM, Sedmak DD: Viral effects on antigen processing. Curr Opin Immunol 1999;11: 94-99.
51. Miller DM, Zhang Y, Rahill BM, Kazor K, Rofagha S, Eckel JJ, Sedmak DD: Human cytomegalovirus blocks interferon-gamma stimulated upregulation of MHC class I expression and the class I antigen processing machinery. Transplantation, in press.
52. Miller DM, Rahill BM, Boss JM, Lairmore MD, Durbin JE, Waldman WJ, Sedmak DD: Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med 1998;187:675-683.
53. Zhu H, Cong JP, Shenk T: Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: Induction of interferon-responsive RNAs. Proc Natl Acad Sci USA 1997; 94:13985-13990.
54. Navarro L, Mowen K, Rodems S, Weaver B, Reich N, Spector D, David M: Cytomegalovirus activates interferon immediate-early response gene expression and an interferon regulatory factor 3-containing interferon-stimulated response element-binding complex. Mol Cell Biol 1998;18:3796-3802.
55. Miller DM, Zhang Y, Rahill BM, Waldman WJ, Sedmak DD: Human Cytomegalovirus inhibits IFN-alpha-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction. J Immunol 1999;162:6107-6113.
56. Abendroth A, Arvin A: Varicella-zoster virus immune evasion. Immunol Rev 1999;168: 143-156.